Find an expert

Dr Odette Leiter is a postdoctoral research fellow in the research group of Dr Tara Walker, investigating systemic brain rejuvenation. She was awarded a PhD in Neuroscience in 2018 by the Technische Universität Dresden in Germany. Her research focus lies on the regulation of adult hippocampal neurogenesis by physical exercise, a process critically involved in learning and memory.

To support her research at the Queensland Brain Institute, Dr Odette Leiter has received two postdoctoral fellowships, a postdoctoral fellowship from the German Academic Exchange Service, followed by a Walter Benjamin Fellowship awarded by the German Research Foundation, allowing her to investigate the role of platelets in mediating neurogenesis-related learning and memory, and the capacity of platelet-released factors to restore cognitive function in ageing. More recently, Dr Leiter has been awarded a Discovery Early Career Researcher Award (DECRA) to investigate the precise mechanisms through which platelets interact with adult hippocampal neural stem cells following exercise.

Dr. Sherman Leung is the Head of Research Operations at Wesley Research Institute - the research partner of UnitingCare. UnitingCare is the largest private employer in Queensland, encompassing four hospitals (The Wesley Hospital, St. Andrew's War Memorial Hospital, Buderim Private Hospital and St. Stephen's Hospital), as well as significant community-based offerings through Lifeline, Blue Care, Family and Disability Services, and ARRCS.

Dr. Leung is a PhD trained scientist, conducting his research training at Mater Research Institute, The University of Queensland, during which his research was published in highly regarded peer-reviewed journals, including in 'Diabetes', receiving the Cover Image, an 'In This Issue' feature, and shared across the Australian-wide 7 Network news.

He has extensive experience in clinical trials, having worked at Microba Life Sciences, an ASX-listed biotechnology start-up, and Nucleus Network, Australia’s largest early phase clinical trial site having overseen the conduct of several high-profile COVID-19 projects including Nuvaxovid by Novavax that has been granted emergency authorisation in 40 countries including by the TGA, EMEA & FDA.

He contributes his spare time to the greater good through numerous initiatives in the industry including being a Board Director of the Australian Clinical Trials Alliance (ACTA), Editorial Board for 'Trials' – a BMC journal promoting all aspects of trials including methods, processes and non-significant outcomes for transparency in the field – being a former member of the Metro North Human Research Ethics Committee (HREC), and offering regular guest classrooms on clinical trials, informed consent and ethics at The University of Queensland.

A/Prof Janni Leung (PhD) is an NHMRC Development Fellow at National Centre for Youth Substance Use Research (NCYSUR) at The University of Queensland. Their program of research includes investigating the epidemiology of substance use and mental health because they are both major public health issues that commonly occur together. This research program had made paradigm-changing development through 100+ articles, which have recognised impact (15,000+ cites, 30% output in the top 1% citation percentile). Many of their work involves conducting systematic reviews, meta-analyses, and applying statistical models to epidemiological data on addiction and mental health issues to better understand their impacts on populations. Her work is used to inform policies on how to reduce the disease burden caused by addiction and mental health problems in Australia and overseas. Janni is committed to conducting high-quality rigorous research to generate empirical epidemiological evidence to inform decisions to prevent addiction-related harms in the population.

Teaching and supervision: They have qualifications and training in public health, sociology, and psychology. In addition, they have strong research and teaching experience in epidemiology and biostatistics. Janni has worked with a range of students from diverse demographic and cultural backgrounds, including mature-aged students and students with family responsibilities. She currently has a topic available for a self-motivated student interested in addiction research. Janni’s current research focus is on the epidemiology and disease burden associated with mental and substance use disorders across the globe.

Consultation: Janni is available for private consultation and workshop presentations on request for various research methodological and statistical topics, e.g. systematic reviews and meta-analysis, questionnaire and survey designs, cross-sectional and longitudinal analyses.

Where can you find Janni: Janni is based at the UQ St Lucia campus with regular visits to the Long Pocket and Herston campuses. You may also catch Janni at the APSAD conference.

Dr. Joan Li is a Senior Lecturer and a Research Fellow with an established national and international reputation at The University of Queensland. She holds both an MD and a PhD, blending clinical and scientific expertise, which provides her with a unique perspective on research and education. While establishing an emerging profile in medical education, she maintains engagement in discipline-related biomedical research through collaboration and supervision.

With over seven years of teaching experience, Joan has actively engaged in face-to-face teaching in biomedical science and medicine courses, contributed to curriculum design, development, and course coordination for both undergraduate and postgraduate programs. She brings her strong analytical skills and critical thinking abilities, honed through her medical and biomedical research background, to her teaching practices. Driven by a genuine passion for teaching, Joan continuously strives for excellence, with specific interests in assessment, curriculum design, development and student learning experience. She has implemented innovative teaching methods, designed diverse and inclusive curricula, created new learning activities, and fostered student engagement as learning partners, with a consistent goal of improving curriculum quality and enhancing student learning outcomes.

Leveraging her medical knowledge, extensive experience in biomedical research, and growing understanding of medical education, Joan is committed to developing medical students into critical thinkers and lifelong learners with a genuine appreciation for medical practice and medical research, enabling them to better serve an ever-changing society. Drawing upon her extensive experience in developmental biology and physiology, particularly in cardiac and renal research, Joan actively supervises higher degree research students and continues to make significant contributions to discipline-related research through publications and collaborations.

Dr. Joan Li is a versatile academic professional with a rich background in biomedical research and an emerging presence in medical education research. Her dedication to teaching and learning, combined with her impressive track record in both disciplines, makes her a valuable asset to The University of Queensland and the broader academic community.

Zhiqi Liang is a Specialist Musculoskeletal Physiotherapist and Lecturer in Physiotherapy at the University of Queensland. She teaches on the Master of Physiotherapy (Musculoskeletal) Program and maintains a clinical role at the Headache Clinic in the University of Queensland. Her research is on neck pain and headache, especially migraine, exploring mechanisms of neck pain in headache and treatment directions, including patient preferences, for individualised management. In 2024, she was awarded the David Lamb Award by the International Federation of Manual and Musculoskeletal Physical Therapists Incorporated (IFOMPT) for high quality research that has made an impact to musculoskeletal physiotherapy internationally. Zhiqi has been a musculoskeletal physiotherapist for more than 15 years and her clinical expertise is recognised by Fellowship within the Australian College of Physiotherapists, where she has been actively involved as an examiner and facilitator for the Specialisation Training Program and currently serves on the Board of Censors.

Jacki Liddle is a research fellow and occupational therapist researching quality of life, participation and life transitions. She uses innovative technology, along with qualitative and quantitative research methods to investigate the needs and experiences of people living with neurological conditions (dementia, Parkinson's disease, stroke), older people and their caregivers. She has worked with a multi-disciplinary team co-designing technology with people living with dementia and their care partners to support communication. Currently, she is in a conjoint position with Princess Alexandra Hospital, supporting the development, conduct and application of research that improves outcomes for patients.

She has also been involved in developing technology to measure outcomes including lifespace, time use, and activity and role participation to help monitor and improve community outcomes. Dr Liddle's PhD focused on researching the experiences related to retirement from driving for older people, which led to the development of the CarFreeMe program to improve outcomes related to driving cessation. Versions of the program for older drivers, people living with dementia and people with traumatic brain injury have been developed and trialled.

Dr Malcolm Lim is an experienced Cancer Biologist and His research interest spans cancer biology, biomarker discovery and theranostic nanomedicine.

He received his PhD from the University of Queensland (UQ) in 2022. His research, conducted in the labs of Professors Sunil Lakhani and Kristofer Thurecht, involved evaluating the efficacy of using nanomedicine for precision delivery of chemo- or radiotherapeutics against biomarkers in brain metastases. For this work, he developed a clinically-relevant brain metastasis mouse model. His research was recognised with the UQ Dean’s Award for Outstanding Thesis 2022. (DOIs: 10.1021/acs.molpharmaceut.3c00558, 10.3791/64216)

Currently, Malcolm serves as a Postdoctoral Research Fellow at the ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) and the Thurecht’s Lab at UQ-Centre for Advanced Imaging (CAI) in Australian Institute for Bioengineering and Nanotechnology (AIBN), where he will apply his multidisciplinary expertise to explore radiobiology and radiation-induced biological responses and to advance targeted pharmaceuticals for challenging cancers.

Prior to joining AMTAR, Malcolm served as a Postdoctoral Researcher where he investigated the molecular mechanisms underlying Early Breast Cancers at the Molecular Breast Pathology Lab, UQ-Centre for Clinical Research, under the mentorship of Professors Sunil Lakhani and Peter Simpson. Before his academic career, Malcolm had five years of experience as a histologist, which provided him with a broad skillset in the field.

Dr Malcolm’s research is well-documented in numerous publications in biomedical research journals despite his career stage, reflecting his passion to advancing cancer research.

Junxian Lim is an accomplished molecular biologist at the Institute for Molecular Bioscience. With a strong background in cell biology, protein biochemistry, and pharmacology, he has established himself in the field. Collaborating with researchers at universities, institutions, as well as international industry partners like AstraZeneca and Sosei Heptares, he has contributed significantly to advancing scientific knowledge.

Throughout his doctoral studies, Junxian authored seven ground-breaking studies focused on the development of novel bioactive inhibitors targeting immune cells and inflammatory diseases. These contributions have paved the way for innovative approaches to drug development. Utilizing his expertise, he has successfully developed and characterized a diverse range of protein and cellular assays that enable in-depth investigations into immunity and inflammation. His research findings have been published in prestigious scientific journals, including Nature Communications, Cell Reports, Journal of the American Chemical Society, Diabetes, Journal of Medicinal Chemistry, and the British Journal of Pharmacology. His work has been highly cited, reflecting its impact and significance within the scientific community.

Recognized for his outstanding mentoring abilities, Junxian has supervised or co-supervised the research of two completed PhD students, six completed MPhil students, and three completed Honours students. The success of his former students is a testament to his dedication and guidance. They continue to excel and actively contribute to research endeavours around the world, spanning countries such as Australia, Singapore, Korea, India, Japan, and China.

Beyond his research and mentoring achievements, Junxian actively participates in the scientific community. He serves on the editorial boards of esteemed journals like Journal of Translational Medicine, Frontiers in Molecular Biosciences and Biology. This involvement allows him to stay at the forefront of scientific advancements and contribute to the dissemination of knowledge within his field.

Carmen is an NHMRC Emerging Leadership Fellow at the National Centre for Youth Substance Use Research. She is passionate about understanding why young people start using substances and dedicated to advance public health through her research. She leads a research program focused on the etiology of youth vaping and drug use, using social media data for surveillance to track trends and tackle emerging challenges. Carmen is also interested in exploring the disparities in substance use in low- and middle-income countries where she aims to deepen her understanding of substance use patterns and develop effective preventative initiatives, striving to create equitable solutions that address the unique challenges faced in these region.

Carmen has qualifications in biostatistics, public health and epidemiology and experiences in teaching and mentoring. She has published over 100 peer-reviewed papers in addiction and mental health (Google Scholar: >8.8K citations, h-index = 37, 31% output in top 10% citation percentile). She has supported and mentored students from diverse demographic and cultural backgrounds. She’s on the lookout for self-driven, curious students with backgrounds in public health, psychology, epidemiology, or statistics to join her team.

Prof Lipman is Executive Director of the Burns Trauma & Critical Care Research Centre; Professor of Anesthesiology & Critical Care, The University of Queensland and until recently (for 23 years) was Director of Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital; He holds Honorary Professorial appointments at Chinese University of Hong Kong, Unversity of Witwatersrand (South Africa) and Qeensland University of Technology.

He has qualifications in anesthesia and intensive care and has set up and been in charge of a number of Intensive Care and Trauma Units in South Africa before coming to Australia in 1997. he currently manages a large multidisciplinary research team with an output of over 120 peer-reviewed articles per annum. He has supervised dozens of PhD students to completion and is currently supervising 6 PhD, 1 MPhil and 1 MBBS/Hons students. Prof Lipman has been instrumental in developing the anaesthesiology and critical care component of a graduate medical program for Queensland and continues to lecture to medical and postgraduate students.

Prof Lipman is the author of over 550 peer reviewed publications, 30 book chapters and has been invited to deliver over 120 lectures at national and international conferences in many countries across the world. His research interests include all aspects of infection management in intensive care and he has a special interest in the pharmacokinetics of antibiotic dosage, an area in which he received his MD in 2006. His research into antibiotic usage in acute situations has received international recognition and he is regarded as an expert in the field. As such, he and his research team have conducted and presently conduct a number of clinical trials in Australia, New Zealand, Hong Kong, Europe and the UK.

Prof Lipman is an Editorial Board member for 10 International Journals, is Section Editor on four Antibiotic related Journals, reviews for 23 journals and is an external reviewer for NHMRC project grants (Local) as well as equivalent for a number overseas countries.

He is Chief Investigator on a 7000 patient International Randomised Controlled Trial comparing bolus dosing versus continuous infusions of meropenem and piperacillin-tazobactam

Dr Liu is a research fellow with more than 15 years of experience in the field of pharmacometrics. She specialises in population pharmacokinetic modelling and provides popPK analysis and dosing simulation support for various projects in Centre of Research Excellence RESPOND

Transporters for Catecholamines and Serotonin. Science Education.

The overall theme of Lesley Lluka's research over 3 decades has been the structure and function of the noradrenaline transporter (NET) and the serotonin transporter (SERT). These transporters are important sites of action of drugs such as antidepressants.

More recently, Lesley Lluka's work has increasingly moved to Science Education, with a focus on areas such as student engagement in practical classes, innovative assessment practices to drive deep learning, and internationalization of the curriculum.

Benignus is a geriatrician who is passionate about working collaboratively within multi-disciplinary teams to deliver exceptional patient-centred care. He currently holds staff specialist appointments at Mater Hospital Brisbane and The Prince Charles Hospital.

He has a strong interest in research and has embarked on a PhD examining frailty and goals of care in patients living with chronic kidney disease. He holds an appointment working as a clinical academic in Professor Hubbard’s team at the University of Queensland’s Centre for Health Services Research with a particular remit to support interdisciplinary education and training about frailty.

Prior to his medical training Benignus worked for KPMG, a professional services firm.

Dr Kristiana Ludlow is a Senior Research Fellow at the Centre for Health Services Research, Faculty of Health, Medicine, and Behavioural Sciences, the University of Queensland, and an Honorary Postdoctoral Fellow at the Australian Institute of Health Innovation, Macquarie University. She completed her Bachelor of Psychology with first class Honours in 2015, her Master of Research in Medicine and Health Sciences in 2017, and her PhD in in Health Innovation in 2020. Dr Ludlow has expertise in co-design, qualitative research and Q methodology. Her research interests include co-designing interventions and digital health tools with end-users, frailty, education, aged care, person-centred care, the role of family caregivers in care, missed care/unfinished care, and care prioritisation. She is passionate about collaborating with consumers, service users and health professionals to improve the delivery of healthcare and mental health services.

Over 5 years of experience in translational biomedical research, specialising in monoclonal antibody-based therapies, immuno-oncology, target discovery and theranostics in cancer. My main research focus is on targeted cancer therapies, understanding how target receptor endocytosis affects antibody drug conjugate (ADC) and radioligand therapy delivery, immune-mediated ADCC, and how combination therapies with immune checkpoint inhibitors can potentially improve therapeutic outcomes for patients.